Candel Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
CADL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
117 Kendrick Street, Suite 450, Needham, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/8/2023

Candel Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Laura K. Aguilar 10%+ Owner $2.74 M May 6, 2022
Paul Peter Tak Chief Executive Officer, Director $336 K Nov 28, 2023
Jason Amello Chief Financial Officer $182 K Nov 28, 2023
Francesca Barone Chief Scientific Officer $168 K Nov 28, 2023
Seshu Tyagarajan Chief Technology Officer $157 K Nov 28, 2023
William Garrett Nichols Chief Medical Officer $122 K Nov 28, 2023
Charles Schoch Interim Chief Financial Officer; Exhibit 24 - Power of Attorney $71.4 K Jan 12, 2024
Udi Meirav Director $43.9 K Jul 26, 2021
Smith Alan E Director $29.3 K Jul 26, 2021
Nathan Caffo Chief Business Officer $5.4 K Jul 29, 2021
John Canepa Chief Financial Officer Feb 28, 2022
Gary J. Nabel Director Jun 26, 2024
Shaan-Chirag C. Gandhi Director Jul 26, 2021
Paul B. Manning Director Jun 26, 2024
Susan B. Stewart Chief Regulatory Officer Apr 11, 2022
Renee Gaeta Director Jun 26, 2024
Edward J. Benz JR Director Jun 26, 2024
Diem Nguyen Director Jun 26, 2024
Joseph C. Papa Director Jun 26, 2024
Christopher Martell Director Jun 26, 2024
Estuardo Aguilar-Cordova Director Jun 28, 2023
Nicoletta Loggia Director Jun 26, 2024

Recent Insider Transactions by Companies or Individuals for Candel Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership